Violet (Viola odorata)

Violet (Viola odorata) contains bioactive compounds including cyclotides and saponins that primarily work through anti-inflammatory and mild sedative pathways. Clinical research demonstrates significant improvements in insomnia severity and faster recovery from respiratory symptoms.

Origin & History

Violet (Viola odorata) is a perennial herbaceous plant native to Europe, Asia, and parts of North Africa, commonly known as sweet violet. The flowering aerial parts are typically processed into syrups, oils, or hydroalcoholic extracts through decoction, distillation, or maceration methods.

Historical & Cultural Context

Viola odorata has centuries of use in Persian and Iranian traditional medicine for respiratory symptoms including cough and dyspnea, as well as for insomnia, headaches, and influenza-like illnesses. Its use as a complementary remedy spans multiple traditional medicine systems across its native regions.

Health Benefits

• Reduces insomnia severity - meta-analysis of 141 patients showed significant improvement in ISI scores (MD -6.30, P=0.009)
• Alleviates COVID-19 symptoms - RCT (n=108) demonstrated faster reduction in cough, myalgia, headache, and diarrhea when added to standard care
• Improves prostate symptoms - small RCT showed improved IPSS scores after 2 weeks of extract supplementation
• Reduces migraine frequency and severity - RCT (n=88) found significant improvements when combined with Rosa damascena and Coriandrum sativum
• Relieves allergic rhinitis symptoms - double-blind RCT demonstrated effectiveness of flower oil preparation

How It Works

Violet's cyclotides and saponins modulate GABAergic neurotransmission, contributing to sedative effects that improve sleep quality. The plant's mucilage compounds provide demulcent properties that soothe respiratory tract inflammation. Anti-inflammatory cyclotides may also inhibit pro-inflammatory cytokine production, supporting immune system recovery.

Scientific Research

Clinical evidence includes several small RCTs and one meta-analysis focused on insomnia (3 studies, n=141). Notable trials include a COVID-19 study (n=108), migraine combination therapy (n=88, PMID: 29765566), and multiple insomnia studies (PMIDs: 38177831, 32073874, 25763239, 35734476). Most studies used violet as add-on therapy rather than standalone treatment.

Clinical Summary

A meta-analysis of 141 patients showed violet supplementation significantly reduced insomnia severity scores by 6.30 points (P=0.009) compared to placebo. An RCT involving 108 COVID-19 patients demonstrated that violet extract added to standard care accelerated recovery from cough, myalgia, headache, and diarrhea. The clinical evidence is moderate but promising, though larger long-term studies are needed. Most research has focused on short-term symptom relief rather than chronic conditions.

Nutritional Profile

Viola odorata leaves and flowers contain moderate vitamin C (approximately 150-200 mg/100g fresh weight), placing them among the higher vitamin C-containing edible flowers. Vitamin A precursors (beta-carotene) are present at approximately 3-5 mg/100g. The plant is a notable source of rutin (quercetin-3-rutinoside) at concentrations of 1.2-3.8 mg/g dry weight, alongside quercetin, kaempferol, and anthocyanins (primarily delphinidin and cyanidin glycosides) which account for the characteristic violet pigmentation. Total flavonoid content ranges from 12-28 mg quercetin equivalents/g dry extract. Cyclotides (small disulfide-rich cyclic peptides such as cycloviolacin O1 and varv peptides) are distinctive bioactive compounds found at approximately 0.1-1.0 mg/g dry plant material, with demonstrated membrane-disrupting bioactivity. Saponins (oleanolic acid derivatives) are present at 2-5% dry weight. Mucilaginous polysaccharides, primarily composed of arabinose and galactose residues, contribute to the plant's traditional use for respiratory mucosa. Salicylic acid derivatives (methyl salicylate) are present in trace amounts. Crude fiber content is approximately 3-5 g/100g fresh weight. Protein content is modest at 1.5-2.5 g/100g fresh weight. Iron content is approximately 1.2-2.0 mg/100g. Bioavailability note: Flavonoid bioavailability is moderate; rutin requires gut microbial deglycosylation to quercetin prior to absorption, estimated systemic bioavailability 20-50%. Cyclotide stability is notably high due to cyclic cystine-knot structure, resisting enzymatic degradation.

Preparation & Dosage

Clinically studied doses include: Syrup (unspecified concentration) for 7 days in COVID-19; Extract 1 mL twice daily for prostate symptoms; Various syrup/extract preparations for insomnia. No standardized dosing or extract specifications were reported in trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Rosa damascena, Coriandrum sativum, Valerian root, Passionflower, Chamomile

Safety & Interactions

Violet supplements are generally well-tolerated with mild gastrointestinal upset being the most common side effect. No significant drug interactions have been reported in clinical studies, though theoretical concerns exist with sedative medications due to potential additive effects. Pregnant and breastfeeding women should avoid violet supplements due to insufficient safety data. Individuals with known allergies to plants in the Violaceae family should exercise caution.